Is the mitral valve area flow-dependent in mitral stenosis?
A dobutamine stress echocardiographic study
Jagdish C. Mohan, MD*,
Ayan R. Patel, MD, FACC ,
Rajiv Passey, MD*,
Dinesh Gupta, MD*,
Manoj Kumar, MD*,
Ramesh Arora, MD* and
Natesa G. Pandian, MD, FACC ,*
* Department of Cardiology, G. B. Pant Hospital, New Delhi, India
Cardiovascular Imaging and Hemodynamic Laboratory, Tufts-New England Medical Center, Boston, Massachusetts, USA

View larger version (30K):
[in a new window]
|
Figure 1 Changes in cardiac output during dobutamine administration in group I (A) and group II (B). *p < 0.0001 compared to baseline.
|
|

View larger version (30K):
[in a new window]
|
Figure 2 (A) Changes in planimetered mitral valve area (MVA) during dobutamine infusion in group I. (B) Changes in MVA derived by the pressure half-time method during dobutamine infusion in group I. *p < 0.0001, p = 0.0002 compared with baseline.
|
|

View larger version (29K):
[in a new window]
|
Figure 3 (A) Changes in planimetered mitral valve area (MVA) during dobutamine infusion in group II. (B) Changes in MVA derived by the pressure half-time method during dobutamine infusion in group II. *p = 0.0035, p = 0.001 compared with baseline.
|
|
|